PricesAustralia · Checked · Rechecked monthly
Wegovy Cost Australia 2026: Price by Dose and PBS Status
In November 2026 one Wegovy pen, which lasts four weeks, costs $249 – $259 for 0.25 mg and $389 for 2.4 mg in Australian dollars. Wegovy for weight loss is not on the PBS, so you pay the private price. Tap your dose to see what it costs.
Tap your dose (mg)
0.25 mg pen · 4 weekly doses · private price
$249 – $259
Per weekly dose$62 – $65
A year at this dose (13 pens)$3,236 – $3,367
With PBS subsidyNot listedPrices are in Australian dollars, taken from public price lists for online prescription uploads.
Your dose goes up in steps, so the price you pay changes with it.
See when your Wegovy dose goes upThe schedule runs from 0.25 mg to 2.4 mg in five steps.
By doseWhy prices differPBSPer yearvs MounjaroOther countriesFAQ
Wegovy price Australia by dose
Wegovy comes in five strengths, from 0.25 mg to 2.4 mg. One pen holds four weekly doses of a single strength, so one pen is one month of treatment.
Where two numbers show, the first is the lowest price we found and the second is the highest, across the Australian price lists we checked in November 2026. A single number means one price for that dose.
The price stays almost flat for the first three doses, then jumps. Moving from 0.25 mg to 0.5 mg adds $0 – $10 a month and 0.5 mg to 1 mg adds $10. The step from 1 mg to 1.7 mg adds $120.
After that the price stops climbing. 1.7 mg and 2.4 mg cost the same, so the highest dose adds $0 to the pen price.
Why Wegovy cost differs in Australia
With no PBS price, each seller sets its own. The lowest 0.25 mg pen we found was $248.95 and the lowest 2.4 mg pen was $389.
Lowest price per pen, November 2026
0.25 mg$248.95
0.5 mg$259
1 mg$269
1.7 mg$389
2.4 mg$389
Prices are close from seller to seller. Only the starter pen shows a gap, between $248.95 and $259.
The price lists we used are for online prescription uploads and say they can change. Check the seller's own page for the dose you need before you order.
The cost shown here is for one pen. Your doctor's visit is a separate cost, and Medicare can apply to that visit. It does not lower the price of the pen.
Is Wegovy on the PBS?
No. As of 20 November 2026 Wegovy is not on the Pharmaceutical Benefits Scheme for weight loss.
The PBAC, the committee that advises on PBS listings, recommended Wegovy in November 2025 for people with obesity and established cardiovascular disease. The recommendation came with a price cut and a risk-sharing arrangement. The PBS status page still shows the listing as not yet occurred.
When a medicine is listed, a general patient pays up to A$25 and a concession card holder pays A$7.70. Wegovy is not on that scheme today, so those charges do not apply to it.
The full PBS history, dates and what a listing would cover are on one page.
Check if Wegovy is on the PBSThe page is updated when the PBS status changes.
Wegovy cost per month and per year
One pen covers four weeks, so the pen price is your monthly cost. A year takes 13 pens, not 12.
Most people do not stay on one dose. You start at 0.25 mg and your prescriber raises the dose step by step. Pick the dose you expect to stay on to see the first-year cost.
I plan to stay on
Earliest you reach itWeek 5Pens at that dose12 of 13First-year cost$3,357 – $3,367
A first year that stays on 0.5 mg comes to about $3,357 – $3,367. Settling on 1 mg comes to about $3,467 – $3,477, and climbing to 1.7 mg or 2.4 mg as fast as the schedule allows comes to about $4,667 – $4,677.
Your prescriber decides which dose you stay on. A lower dose that works for you also keeps the yearly bill down.
Wegovy vs Mounjaro and Ozempic cost in Australia
Wegovy costs less than Mounjaro at the starter dose and at the top dose. Its starter pen is $249 – $259 and the 2.4 mg pen is $389, against $270 – $285 and $665 – $689 for the lowest and highest Mounjaro doses in Australian dollars.
Price per pen, four weeks of treatment
Starter doseWegovy $249 – $259 · Mounjaro $270 – $285
Highest doseWegovy $389 · Mounjaro $665 – $689
Ozempic has the same active ingredient as Wegovy. A 1 mg Ozempic pen costs A$160 on a private prescription, against A$269 for a 1 mg Wegovy pen. Ozempic is licensed for type 2 diabetes, and the PBS lowers its price to a patient charge of A$25 only for that use.
The medicines differ in dose steps and in average weight loss, so price is only part of the choice. See Mounjaro cost in Australia for every Mounjaro dose, Ozempic cost in Australia for the diabetes pen, and what Wegovy is for how it works.
Wegovy price in other countries
Prices differ between countries. See the Wegovy price in the UK for pounds per dose and the Wegovy cost in the US for US dollars.
There are also pages for the Wegovy price in Canada and India. Wegovy price by country puts them side by side.
Wegovy cost Australia FAQ
Is the semaglutide price the same as the Wegovy price?
Not always. Semaglutide is the ingredient in both Wegovy and Ozempic, and each brand has its own price. For weight loss the pen to price is Wegovy, which starts at $249 – $259 a month.
Does Medicare cover Wegovy?
No. Medicare does not lower the price of the pen because Wegovy is not on the PBS. It can still apply to the doctor visit where you get the prescription.
Does one Wegovy pen really last a month?
Yes. One pen holds four weekly doses, so a pen lasts four weeks and a year takes 13 pens.
How much would Wegovy cost if it joins the PBS?
A general patient would pay up to A$25 a script, or A$7.70 with a concession card. No listing date has been announced, so do not plan around that price yet.
Keep reading
Wegovy on the PBS: is it listed and what it costs
Wegovy dosing chart: the dosing schedule week by week
GLP1 Note rechecks the prices on this page every month against public price lists and official sources. The next check is in December 2026. See how we check prices.
Update log
: First published. Prices taken from public Australian price lists.
Sources
Public price lists of Australian pharmacies for online prescription uploads, opened 19–20 November 2026.
Pharmaceutical Benefits Scheme, medicine status: semaglutide (Wegovy), information current at 1 November 2026.
Pharmaceutical Benefits Scheme, PBAC advice on equitable access to GLP-1 obesity treatments.
Pharmaceutical Benefits Scheme, current patient fees and charges.
Pharmaceutical Benefits Scheme, Ozempic, PBS item 14846J.
GLP1 Note is an independent information site and does not sell medicines. Prices change, so check the seller's own page before you order.